A multidisciplinary group of scientists, clinicians, engineers, and advisors working to transform brain therapeutics from discovery through delivery.
PhD, CSIR-IGIB. Former postdoctoral researcher at Columbia University Irving Medical Center and Memorial Sloan Kettering Cancer Center. A DBT-WLSE awardee, she leads scientific vision, product strategy, partnerships, and translational research.
MBA, University at Buffalo, with a background in biotechnology and expertise in pharmaceutical business and commercial strategy.
PhD, CSIR-CDRI. Cell biologist with expertise in molecular pharmacology, therapeutic delivery systems, and translational biomedical research.
PhD, Kelley School of Business, Indiana University. University at Buffalo School of Management advisor supporting innovation strategy, venture development, commercialization pathways, and partnership readiness.
IIT Delhi and Yale School of Medicine. Professor of Chemical Engineering at IIT Delhi and scientific advisor with expertise in bioprocess engineering, manufacturing strategy, nanovesicle scale-up, drug delivery, and translational healthcare technologies.
Founder, Bench2BIO. Head consultant and strategist (ex-Pfizer, ex-BeiGene) with 15+ years across pharma, startups, and venture, helping scientists and founders turn breakthrough ideas into real-world impact.